Keywordschemokine; chemokine receptor; regulation; binding; expression; glycosaminoglycan; post-translational modification; oligomerization; signaling; inhibitor; chemokine; CXCL7; NAP-2; CXCR2; glycosaminoglycan; heparin; NMR; monomer; cow; endometrium; chemokines; tissue culture; pregnancy; chemokine; heterodimer; CXCL7; CXCR2; glycosaminoglycan; heparin; NMR; chemokine; chemokine receptor; reverse signaling; cellular communication; brain tumor; glioma; tumor cell migration; chemokine; glycosaminoglycan; leukocyte migration; posttranslational modification; CXCR3; dipeptidyl peptidase IV; CD26; 5P12-RANTES; Chemokine (C-C Motif) Ligand 5 (CCL5); HIV entry inhibition; N-terminal cyclization; chemokine; chemokine-GAG interaction; synthetic peptide chemistry; PTM; chemokine nitration; chemokine binding protein; chemokine analog; anti-inflammation; 35K; vCCI; vMIP-II; MIP-1β/CCL4; molecular dynamics; chemokines; chemokine receptors; NMR; sulfotyrosine; CCL21; CCL19; CCR7; cancer metastasis; posttranslational modification; CXCL5; CXCL8; CXCR1; CXCR2; sulfotyrosine; post-translational modification; chemokines; NMR; chemokine; structure; NMR; heterodimers; interactome; n/a
